Compugen (CGEN)
(Delayed Data from NSDQ)
$1.92 USD
+0.02 (1.05%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $1.91 -0.01 (-0.52%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Income Statements
Fiscal Year end for Compugen Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 33 | 8 | 6 | 2 | 0 |
Cost Of Goods | 2 | 1 | 1 | 0 | 0 |
Gross Profit | 31 | 7 | 5 | 2 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 44 | 42 | 40 | 33 | 29 |
Income After Depreciation & Amortization | -13 | -35 | -35 | -32 | -29 |
Non-Operating Income | 3 | 2 | 1 | 2 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -10 | -34 | -34 | -30 | -28 |
Income Taxes | 9 | 0 | 0 | 0 | -1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -19 | -34 | -34 | -30 | -27 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -19 | -34 | -34 | -30 | -27 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -13 | -35 | -35 | -31 | -28 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 1 | 1 |
Income After Depreciation & Amortization | -13 | -35 | -35 | -32 | -29 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 87.63 | 86.56 | 84.20 | 79.59 | 63.64 |
Diluted EPS Before Non-Recurring Items | -0.21 | -0.39 | -0.41 | -0.37 | -0.43 |
Diluted Net EPS (GAAP) | -0.21 | -0.39 | -0.41 | -0.37 | -0.43 |
Fiscal Year end for Compugen Ltd falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 33.46 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 2.00 | NA | 0.00 | 0.00 |
Gross Profit | NA | 31.46 | NA | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 13.47 | 10.63 | 10.21 | 10.14 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 17.99 | -10.63 | -10.21 | -10.14 |
Non-Operating Income | NA | 0.74 | 0.78 | 0.89 | 0.81 |
Interest Expense | NA | 0.00 | NA | 0.00 | 0.00 |
Pretax Income | NA | 18.72 | -9.85 | -9.33 | -9.33 |
Income Taxes | NA | 9.01 | NA | -0.05 | 0.01 |
Minority Interest | NA | 0.00 | NA | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | NA | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | NA | 0.00 | 0.00 |
Income From Cont. Operations | NA | 9.71 | -9.85 | -9.28 | -9.34 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 9.71 | -9.85 | -9.28 | -9.34 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 88.42 | 88.31 | 87.18 | 86.63 |
Diluted EPS Before Non-Recurring Items | NA | 0.11 | -0.11 | -0.11 | -0.11 |
Diluted Net EPS (GAAP) | NA | 0.11 | -0.11 | -0.11 | -0.11 |